FrancophonIA/ELRC3.0 huggingface dataset:
English: In patients with VWD, there is a risk of occurrence of thromboembolic events, particularly in patients with known clinical or laboratory risk factors.
Maltese: F'pazjenti b'VWD, hemm riskju li jseħħu episodji tromboemboliċi, l-aktar f'pazjenti b'fatturi ta' riskju kliniku jew tal-laboratorju magħrufin.
English: Voncento 500 IU FVIII / 1200 IU VWF (5 ml solvent) powder and solvent for solution for injection/infusion
Maltese: IU VWF (5 ml solvent) trab u solvent għal soluzzjoni għallinjezzjoni/infużjoni Voncento 1000
English: One pack contains:
Maltese: Parametri PK inizjali ta' FVIII:
English: Individual patients may vary in their response to factor VIII, demonstrating different half-lives and recoveries.
Maltese: Pazjenti individwali jistgħu jvarjaw fir-rispons tagħhom għall-fattur VIII, li juri li hemm half-lives u rkupru differenti.
English: On-demand treatment
Maltese: TAL-PRODOTT MEDIĊINALI
English: Voncento is supplied as a white powder and solvent for solution for injection/infusion.
Maltese: Voncento huwa fornut bħala trab abjad u solvent għal soluzzjoni għall-injezzjoni/infużjoni.
English: Inhibitors
Maltese: Il-Ġermanja
English: Standard measures to prevent infections resulting from the use of medicinal products prepared from human blood or plasma include selection of donors, screening of individual donations and plasma pools for specific markers of infection and the inclusion of effective manufacturing steps for the inactivation/removal of viruses.
Maltese: Miżuri standard sabiex jiġu evitati infezzjonijiet mill-użu ta' prodotti mediċinali ippreparati middemm jew plażma tal-bniedem jinkludu l-għażla tad-donaturi, screening tad-donazzjonijiet individwali u ta' plażma kollettiva għall-markaturi speċifiċi tal-infezzjoni u li jittieħdu passi effettivi waqt ilmanifattura għal-inattivazzjoni/tneħħija ta' vajrusis.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Solvent vial label 5 ml
Maltese: Ż-ŻGĦAR EWLENIN Tikketta tal-kunjett tas-solvent 5 ml
English: Voncento 250 IU FVIII / 600 IU VWF (5 ml solvent) powder and solvent for solution for injection/infusion Voncento 500 IU FVIII / 1200 IU VWF(10 ml solvent) powder and solvent for solution for injection/infusion Voncento 500 IU FVIII / 1200 IU VWF (5 ml solvent) powder and solvent for solution for injection/infusion Voncento 1000 IU FVIII / 2400 IU VWF (10 ml solvent) powder and solvent for solution for injection/infusion human coagulation factor VIII, human von Willebrand factor
Maltese: trab u solvent għal soluzzjoni għall-injezzjoni/infużjoni kunjett 1 bit-trab kunjett 1 b'5 ml ilma għall-injezzjonijiet Apparat 1 20/20 biex tiffiltra u tittrasferixxi Kaxxa waħda ta' ġewwa li fiha:
English: The pharmacokinetics of Voncento have been evaluated in VWD patients in the non-bleeding state.
Maltese: TWISSIJA SPEĊJALI LI L-PRODOTT MEDIĊINALI GĦANDU JINŻAMM
English: 100 IU/ml FVIII and 240 IU/ml VWF.
Maltese: IU/ml VWF.
English: Voncento 1000 IU FVIII / 2400 IU VWF (10 ml solvent) powder and solvent for solution for injection/infusion
Maltese: IU VWF (10 ml solvent) trab u solvent għal soluzzjoni għall injezzjoni/infużjoni
English: MediSanus d.o.o.
Maltese: Kodiċi ATC:
English: When using a FVIII-containing VWF product, the treating physician should be aware that continued treatment may cause an excessive rise in FVIII:C. After 24 - 48 hours of treatment, in order to avoid an excessive rise in FVIII:C, reduced doses and/or prolongation of the dose interval or the use of a VWF product containing a low level of FVIII should be considered.
Maltese: Interazzjoni ma' prodotti mediċinali oħra u forom oħra ta' interazzjoni Ma ġewx irrappurtati interazzjonijiet ta' VWF u FVIII ma' prodotti mediċinali oħra studjati. 4.6 Fertilità, tqala u treddigħ
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Solvent vial label 10 ml
Maltese: Ż-ŻGĦAR EWLENIN Tikketta tal-kunjett tas-solvent 10 ml
English: Total clearance(mL/(h*kg) Vss (ml/kg)
Maltese: Tneħħija totali (mL/(siegħa*kg))
English: B. PACKAGE LEAFLET
Maltese: Eċċipjent b'effett magħruf
English: --1 Per 1 ml dose: purified p45 FeLV-envelope antigen, minimum quantity 102 µg
Maltese: --1 Għal kull doża ta' 1 ml: kwantità minima ta' antiġen p 45FeLV-envelop ippurifikat 102 µg
English: Pharmaceutical form
Maltese: Għamla Farmaċewtika
English: EU (MA) number Invente d name
Maltese: Numru tal-UE Isem kummerċjali
English: EMA/439670/2014 EMEA/H/C/002445
Maltese: EMEA/H/C/002445
English: The full EPAR for Lyxumia can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Maltese: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The active substance in Lyxumia, lixisenatide, is a ‘GLP-1 receptor agonist'.
Maltese: Is-sustanza attiva f'Lyxumia, il-lixisenatide, hija “agonist tar-riċettur ta' GLP-1”.
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom
Maltese: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom ma' dan ir-riskju. Lyxumia ma għandux jingħata b'kombinazzjoni tat-tnejn, insulina bażali u sulfonilurea.
English: Lyxumia has been studied in seven main studies involving 3,825 adults with type 2 diabetes.
Maltese: Lyxumia ġie studjat f'seba' studji ewlenin li jinvolvu 3,825 adult bid-dijabete tat-tip 2.
English: This is a summary of the European public assessment report (EPAR) for Lyxumia.
Maltese: Dan id-dokument huwa sommarju tar-rapport pubbliku Ewropew ta' valutazzjoni (EPAR) għal Lyxumia.
English: The study comparing Lyxumia with exenatide (added to metformin) showed reduced HbA1c levels by 0.79% after 24 weeks treatment with Lyxumia compared to 0.96% with exenatide twice daily.
Maltese: L-istudju li jqabbel Lyxumia mal-exenatide (flimkien mal-metformina) wera tnaqqis fil-livelli ta' HbA1c b'0.79% wara 24 ġimgħa ta' kura b'Lyxumia meta mqabbel ma' 0.96% b'exenatide darbtejn kuljum.
English: Lyxumia is a diabetes medicine that contains the active substance lixisenatide.
Maltese: Lyxumia huwa mediċina tad-dijabete li fiha s-sustanza attiva lixisenatide.
English: When used in combination with other diabetes medicines, Lyxumia reduced Hb1Ac levels by 0.4 up to 0.9% more than placebo.
Maltese: Meta jintuża ma' mediċini oħra kontra d-dijabete, Lyxumia naqqas il-livelli ta' Hb1Ac b'0.4 sa 0.9% aktar mill-plaċebo.
English: It is available as a solution for injection in a pre-filled pen that provides either 10 micrograms or 20 micrograms of lixisenatide in each dose.
Maltese: Jiġi bħala soluzzjoni għallinjezzjoni f'pinna mimlija minn qabel li tipprovdi 10 mikrogrammi jew 20 mikrogramma ta' lixisenatide f'kull doża.
English: When used on its own, Lyxumia reduced Hb1Ac levels by 0.6% more than placebo.
Maltese: Meta jintuża waħdu, Lyxumia jnaqqas il-livelli ta' Hb1Ac b'0.6% aktar mill-plaċebo.
English: A risk management plan has been developed to ensure that Lyxumia is used as safely as possible.
Maltese: Ġie żviluppat pjan ta' ġestjoni tar-riskju biex jassigura li Lyxumia jintuża bl-aktar mod sigur possibbli.
English: Six of the studies compared Lyxumia with placebo (a dummy treatment), used alone or when added to metformin, a sulphonylurea, basal insulin, or a combination of two of these medicines, in patients in whom previous treatment had failed.
Maltese: Sitta mill-istudji qabblu Lyxumia ma' plaċebo (kura finta), użat waħdu jew meta miżjud mal-metformina, is-sulfonilurea, l-insulina bażali, jew kombinazzjoni ta' tnejn minn dawn il-mediċini, f'pazjenti li l-kura preċedenti tagħhom ma kinitx irnexxiet.
English: Why has Lyxumia been approved?
Maltese: Għaliex ġie approvat Lyxumia?
English: Lyxumia was more effective than placebo at controlling blood glucose.
Maltese: Lyxumia kien aktar effettiv mill-plaċebo biex jikkontrolla l-glukożju fid-demm.
English: What is the risk associated with Lyxumia?
Maltese: X'inhu r-riskju assoċjat ma' Lyxumia?
English: What is Lyxumia?
Maltese: Għalxiex jintuża Lyxumia?
English: What measures are being taken to ensure the safe and effective use of Lyxumia?
Maltese: X'miżuri qegħdin jittieħdu biex jassiguraw użu sigur u effettiv ta' Lyxumia?
English: The European Commission granted a marketing authorisation valid throughout the European Union for Lyxumia on 1 February 2013.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq għal Lyxumia valida fl-Unjoni Ewropea kollha fl-1 ta' Frar 2013.
English: The most common side effects with Lyxumia (seen in more than 1 patient in 10) are nausea (feeling sick), vomiting, diarrhoea and headache.
Maltese: L-effetti sekondarji l-aktar komuni b'Lyxumia (li dehru f'aktar minn pazjent wieħed minn kull 10) huma dardir (tħossok ma tiflaħx), rimettar, dijarrea u wġigħ ta' ras.
English: Allergic reactions have been reported in less than 1 in 100 patients using Lyxumia.
Maltese: Ir-reazzjonijiet allerġiċi kienu rrapportati f'inqas minn pazjent wieħed minn kull 100 li jużaw Lyxumia.
English: These side effects were mostly mild and usually resolved over time.
Maltese: Dawn l-effetti sekondarji ġeneralment kienu ħfief u temporanji.
English: Regarding its safety, most side effects are comparable to those of other similar diabetes medicines with side effects affecting the gut being the most common ones.
Maltese: Firrigward tas-sigurtà tiegħu, il-biċċa l-kbira tal-effetti sekondarji huma komparabbli ma' dawk ta' mediċini oħra simili kontra d-dijabete bl-effetti sekondarji li jaffettwaw l-imsaren ikunu l-aktar komuni.
English: When used together with a sulphonylurea or basal insulin, the most common side effect (seen in more than 1 patient in 10) is hypoglycaemia (low blood glucose levels).
Maltese: Meta jintuża flimkien mas-sulfonilurea jew l-insulina bażali, l-effett sekondarju l-aktar komuni (li deher f'aktar minn pazjent wieħed minn kull 10) huwa ipogliċemija (livelli baxxi ta' glukożju fid-demm).
English: It works by attaching to glucagon-like peptide 1 (GLP-1) receptors that are found on the surface of the cells in the pancreas and that cause the production of insulin by the pancreas.
Maltese: Taħdem billi teħel mar-riċetturi simili għal glucagone peptide 1 (GLP-1) (glucagon-like peptide 1) li jinstabu fuq il-wiċċ taċ-ċelloli talfrixa u li jikkawżaw il-produzzjoni tal-insulina mill-frixa.
English: Type 2 diabetes is a disease in which the pancreas does not make enough insulin to control the level of glucose in the blood or when the body is unable to use insulin effectively.
Maltese: Id-Dijabete tat-tip 2 hija marda li fiha l-frixa ma tipproduċix biżżejjed insulina biex tikkontrolla l-livell ta' glukożju fid-demm jew meta l-ġisem ma jkunx kapaċi juża l-insulina b'mod effettiv.
English: How has Lyxumia been studied?
Maltese: Kif ġie studjat Lyxumia?
English: The CHMP concluded that the benefits of Lyxumia outweigh its risks and recommended that it be granted marketing authorisation.
Maltese: Is-CHMP ikkonkluda li l-benefiċċji ta' Lyxumia huma akbar mir-riskji tiegħu u rrakkomanda li tingħata awtorizzazzjoni għat-tqegħid fis-suq.
English: In addition, beneficial weight loss was seen in patients treated with Lyxumia.
Maltese: Barra minn hekk, kien hemm tnaqqis benefiċċjali fil-piż f'pazjenti kkurati b'Lyxumia.
English: Lyxumia is used in adults who have type 2 diabetes to control their blood glucose (sugar) level.
Maltese: Lyxumia jintuża f'adulti bid-dijabete tat-tip 2 biex jikkontrollalhom il-livell tal-glukożju (zokkor) fiddemm.
English: It is used together with diabetes medicines taken by mouth and/or basal insulin (long-acting insulin) in patients whose blood glucose levels are not adequately controlled by these medicines together with diet and exercise.
Maltese: Dan jikkawża r-rilaxx ta' insulina u jgħin biex inaqqas il-livelli ta' glukożju fid-demm u jikkontrolla d-dijabete tat-tip 2.
English: If the patient is already taking a sulphonylurea (another diabetes medicine) or basal insulin, the doctor may need to reduce the dose of the sulphonylurea or basal insulin because there is a risk of hypoglycaemia (low blood sugar levels).
Maltese: Jekk il-pazjent diġà jkun qiegħed jieħu sulfonilurea (mediċina oħra tad-dijabete) jew insulina bażali, ittabib jaf ikollu jnaqqas id-doża tas-sulfonilurea jew insulina bażali peress li jeżisti r-riskju ta'
English: The CHMP concluded that Lyxumia was shown to be effective at lowering blood glucose levels in patients with type 2 diabetes, when given alone or in combination with other diabetes medicines.
Maltese: Is-CHMP ikkonkluda li Lyxumia ntwera li huwa effettiv biex inaqqas il-livelli ta' glukożju fid-demm f'pazjenti li għandhom id-dijabete tat-tip 2, meta jingħata waħdu jew flimkien ma' mediċini oħra taddijabete.
English: MA (EU) number (Invented) name
Maltese: Isem (inventat)
English: Intravenous use Powder: vial (glass) Solvent: pre-filled syringe (glass)
Maltese: Il-pakkett li jmiss mal-prodott
English: ΦΑΡΜΑΖΑΚ ΑΝΩΝΥΜΗ ΦΑΡΜΑΚΕΥΤΙΚΗ ΕΜΠΟΡΙΚΗ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ Δ.Τ.
Maltese: ΦΑΡΜΑΚΕΥΤΙΚΗ ΕΜΠΟΡΙΚΗ
English: Baclofeno Generis baclofen
Maltese: Baclofeno Generis baklofen
English: Sanofi Aventis France
Maltese: Sanofi Aventis
English: ZYDUS France
Maltese: ZYDUS Franza
English: memantine
Maltese: memantina
English: Morysa memantine
Maltese: Morysa memantina
English: perindopril / indapamide
Maltese: perindopril / indapamid
English: Loperamid Evolan loperamide
Maltese: Loperamid Evolan loperamid
English: Belgium Sandoz n.v./s.a.
Maltese: Il-Belġju Sandoz n.v./s.a.
English: Loperamid Orifarm loperamide
Maltese: Loperamid Orifarm loperamid
English: Bendro-flumetiazid Alternova bendro-flumethiazide 2.5 mg Tablet
Maltese: Bendro-flumetiazid Alternova bendro-flumetijażid 2.5 mg Pillola
English: Buproprionhydrochlorid Hexal 300 mg bupropion
Maltese: Buproprionhydrochlorid Hexal 300 mg bupropjon
English: Alternova A/S Etodolac Alternova etodolac
Maltese: Alternova A/S Etodolac Alternova etodolak
English: Stasisport Pharma N.V.
Maltese: L-Irlanda Stasisport Pharma N.V.
English: Alternova A/S Baklofen Alternova baclofen
Maltese: Alternova A/S Baklofen Alternova baklofen
English: Belfada aripiprazole
Maltese: Belfada aripiprażol
English: Bupropion 1 A Pharma 300 mg bupropion
Maltese: Bupropion 1 A Pharma 300 mg bupropjon
English: Memantine Pharmascope memantine
Maltese: Memantine Pharmascope memantina
English: Carbocisteine 375 mg Capsules, Hard carbocisteine
Maltese: Carbocisteine 375 mg Kapsuli, Ibsin karboċisteina
English: Bupropion Orion bupropion
Maltese: Bupropion Orion bupropjon
English: Paracetamol Almus Pharma paracetamol
Maltese: Paracetamol Almus Pharma paraċetamol
English: SUBSTIPHARM DEVELOPPEMENT
Maltese: SUBSTIPHARM
English: Aurovitas Spain SAU
Maltese: Aurovitas Spanja SAU
English: paracetamol
Maltese: paraċetamol
English: ethinylestradiol / levonorgestrel
Maltese: etinilestradjol / levonorgestrel
English: Corporation Orion Pharma, Finland
Maltese: Il-Finlandja Orion Corporation Orion Pharma, Il-Finlandja
English: Bupropion HCl Sandoz retard 300 mg, tabletten met gereguleerde afgifte bupropion
Maltese: Bupropion HCl Sandoz retard 300 mg, tabletten met gereguleerde afgifte bupropjon
English: Alternova A/S Hydrokortison Alternova hydrocortisone
Maltese: Alternova A/S Hydrokortison Alternova idrokortiżon
English: Aurobindo Pharma (Portugal), Unipessoal Lda.
Maltese: Aurobindo Pharma (IlPortugall), Unipessoal Lda.
English: Slovak Republic SVUS Pharma a.s.
Maltese: Is-Slovakkja SVUS Pharma a.s.
English: dutasteride
Maltese: dutasterid
English: Biogaran hydroxyzine BIOGARAN hydroxyzine
Maltese: Biogaran hydroxyzine BIOGARAN
English: PHARMAZAC AE
Maltese: ΕΤΑΙΡΕΙΑ Δ.Τ. PHARMAZAC AE
English: Loperamid Apofri loperamide
Maltese: Apofri AB Loperamid Apofri loperamid
English: Capsule, soft Oral use
Maltese: Kapsula, iebsa Użu orali
English: Bupropion Sandoz 300 mg tablete s prirejenim sproščanjem bupropion
Maltese: Bupropion Sandoz 300 mg tablete s prirejenim sproščanjem bupropjon
English: Medreich PLC Gliclazide 40 mg tablets gliclazide
Maltese: Medreich PLC Gliclazide 40 mg pilloli gliklażid
English: Beta-histina Basi
Maltese: Beta-histina
English: Omega 3-acid-ethyl esters 1000mg soft capsules omega-3-acid-ethyl esters 90
Maltese: Omega 3-acid-ethyl esters 1000 mg kapsuli rotob omega-3-aċidu-etil esters 90
English: United Kingdom Kinedexe UK Limited (previously
Maltese: Ir-Renju Unit Kinedexe UK Limited (qabel
English: Sodium Cromoglicate 100mg hard Capsules sodium cromoglicate 100 mg Capsule, hard Oral use
Maltese: Sodium Cromoglicate 100 mg Kapsuli ibsin sodju kromoglikat 100 mg
English: 1000 mg Capsule, soft Oral use
Maltese: 1000 mg Kapsula, ratba Użu orali
English: VITAMA S.A.
Maltese: S.A.
English: The Netherlands Pharmascope Ltd.
Maltese: In-Netherlands Pharmascope Ltd.
English: Omega 3 Strides Arcolab International omega-3-acid-ethyl esters 90
Maltese: Omega 3 Strides Arcolab International omega-3-aċidu-etil esters 90
English: Sandoz A/S, Denmark
Maltese: Il-Finlandja Sandoz A/S, IdDanimarka
English: Bupropion-neuraxpharm 300 mg Tabletten mit veränderter Wirkstofffreisetzung bupropion
Maltese: Bupropion-neuraxpharm 300 mg Tabletten mit veränderter Wirkstofffreisetzung bupropjon
English: Metoklopramid Alternova metoclopramide
Maltese: Metoklopramid Alternova metoklopramid 10 mg
English: BBS Consult ApS Loperamid BBS
Maltese: BBS Consult ApS
English: United Kingdom Medreich PLC
Maltese: Ir-Renju Unit Medreich PLC
English: Pharma Bavaria International (PBI) Portugal, Unip.
Maltese: International (PBI) Portugal, Unip. Lda.
English: Prednisolon Alternova prednisolone
Maltese: Prednisolon Alternova predniżolon
English: United Kingdom Strides Arcolab International
Maltese: Ir-Renju Unit Strides Arcolab International
English: Hexal AG, Germany
Maltese: Il-Ġermanja Hexal AG, IlĠermanja
English: Bupropion HCl Sandoz bupropion
Maltese: Bupropion HCl Sandoz bupropjon
English: loperamide
Maltese: loperamid
English: Dicloxacillin Alternova dicloxacillin
Maltese: Dicloxacillin Alternova diklossaċillin
English: 1A Pharma GmbH
Maltese: L-Awstrija 1A Pharma GmbH
English: Mylan Dura GmbH
Maltese: Il-Ġermanja Mylan Dura GmbH
English: Dawa Limited Carbimazole 5mg Tablets carbimazole
Maltese: Dawa Limited Carbimazole 5 mg Pilloli karbimażol
English: omega-3-acid-ethyl esters 90
Maltese: omega-3-aċidu-etil esters 90
English: Sandoz GmbH
Maltese: Is-Slovenja Sandoz Gmbh
English: Irbesartan 300 mg Filmcoated tablets irbesartan
Maltese: Irbesartan 300 mg Film-coated tablets irbesartan
English: Bupropion 1A Pharma 300 mg - Tablette mit veränderter Wirkstofffreisetzung bupropion
Maltese: Bupropion 1A Pharma 300 mgTablette mit veränderter Wirkstofffreisetzung bupropjon
English: Maexeni 30 0,03 mg/0,15 mg Filmtabletten ethinylestradiol / levonorgestrel mg/0.15 mg neuraxpharm Arzneimittel GmbH
Maltese: Maexeni 30 0,03 mg/0,15 mg Filmtabletten etinilestradjol / levonorgestrel
English: Esters ethyliques d'acides omega-3 Strides omega-3-acid-ethyl esters 90
Maltese: Esters ethyliques d'acides omega-3 Strides omega-3-aċidu-etil esters 90
English: Belgium Aurobindo Pharma BV
Maltese: Il-Belġju Aurobindo Pharma BV
English: Naproxen 500 mg tablets naproxen
Maltese: Naproxen 500 mg tablets
English: Gliclazide 80mg Tablets gliclazide
Maltese: Gliclazide 80 mg Pilloli gliklażid
English: EQL Pharma AB
Maltese: L-Iżvezja EQL Pharma AB
English: LARCIA 125 MIKROGRAMŮ/30 MIKROGRAMŮ
Maltese: MIKROGRAMŮ/30
English: United Kingdom Dawa Limited
Maltese: Ir-Renju Unit Dawa Limited
English: United Kingdom Milpharm Limited
Maltese: Ir-Renju Unit Milpharm Limited
English: Dawa Limited Carbimazole 20mg Tablets carbimazole
Maltese: Dawa Limited Carbimazole 20 mg Pilloli karbimażol
English: Paracetamol 500 mg Film Coated Tablets paracetamol
Maltese: Paracetamol 500 mg Film Coated Tablets paraċetamol
English: Hydroxyzine hydrochloride 25mg film-coated tablets hydroxyzine hydrochloride
Maltese: Hydroxyzine hydrochloride 25 mg pilloli miksijin b'rita klorur tal-idrossiżina 25 mg
English: Beta- histina Bluefish betahistine dihydrochloride
Maltese: Beta- histina Bluefish betahistina diidroklorur
English: Gliclazide 40mg Tablets gliclazide
Maltese: Gliclazide 40 mg Pilloli gliklażid
English: Irbesartan 150 mg Filmcoated tablets irbesartan
Maltese: Irbesartan 150 mg Film-coated tablets irbesartan
English: Annex Ib: Products for which the marketing authorisations are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation
Maltese: Anness Ib: Prodotti li għalihom l-awtorizzazzjonijiet għat-tqegħid fis-suq huma rrakkomandati għas-sospensjoni u l-applikazzjonijiet għall-awtorizzazzjoni għat-tqegħid fis-suq li ma jissodisfawx il-kriterji għall-awtorizzazzjoni
English: Orion Corparation
Maltese: In-Norveġja Orion Corparation
English: Etrixenal 250 mg tabletes naproxen
Maltese: Etrixenal 250 mg tabletes
English: Hydroxyzinhydrochlorid EQL Pharma hydroxyzine
Maltese: Hydroxyzinhydrochlorid EQL Pharma idrossiżina
English: Hormosan Pharma GmbH
Maltese: Il-Ġermanja Hormosan Pharma GmbH
English: acide ursodesoxycholique Inopharm ursodeoxycholic acid 500 mg Film-coated tablet
Maltese: acide ursodesoxycholique Inopharm aċidu ursodeossikoliku
English: Carbimazole 20 mg Tablets carbimazole
Maltese: Carbimazole 20 mg Pilloli karbimażol
English: Slovak Republic Proenzi s.r.o.
Maltese: Is-Slovakkja Proenzi s.r.o.
English: Betahistyna Bluefish betahistine dihydrochloride
Maltese: Betahistyna Bluefish betahistina diidroklorur
English: 8 mg/2.5 mg
Maltese: 8 mg/2.5 mg Pillola
English: Voriconazol Glob voriconazol
Maltese: Voriconazol Glob vorikonażol
English: Hydroxyzine EQL Pharma hydroxyzine
Maltese: Hydroxyzine EQL Pharma idrossiżina
English: Carbimazole 5mg Tablets carbimazole
Maltese: Carbimazole 5 mg Pilloli karbimażol
English: Betahistina Bluefish betahistine dihydrochloride
Maltese: Betahistina Bluefish betahistina diidroklorur
English: Naproxen 250 mg tablets naproxen
Maltese: Naproxen 250 mg tablets
English: Voriconazol Aurobindo 200 mg, filmomhulde tabletten voriconazol
Maltese: Voriconazol Aurobindo 200 mg, filmomhulde tabletten vorikonażol
English: voriconazole Arrow voriconazol
Maltese: voriconazole Arrow vorikonażol
English: Voriconazolo Aurobindo voriconazol
Maltese: Voriconazolo Aurobindo vorikonażol
English: PUREN Pharma GmbH & Co. KG
Maltese: Il-Ġermanja PUREN Pharma GmbH & Co.
English: Voriconazol PUREN 200 mg Filmtabletten voriconazol
Maltese: Voriconazol PUREN 200 mg Filmtabletten vorikonażol
English: Voriconazole Milpharm 200 mg film-coated tablets voriconazol
Maltese: Voriconazole Milpharm 200 mg filmcoated tablets vorikonażol
English: Voriconazole Milpharm 50 mg film-coated tablets voriconazol
Maltese: Voriconazole Milpharm 50 mg filmcoated tablets vorikonażol
English: Amlodipina + Valsartan Aurovitas, Amlodipin/Valsartan PUREN (in Germany)
Maltese: Amlodipina + Valsartan Aurovitas, Amlodipin/Valsartan PUREN (filĠermanja)
English: Orion Corporation
Maltese: Il-Polonja Orion Corporation
English: Bupropione Sandoz bupropion
Maltese: Bupropione Sandoz bupropjon
English: Voriconazol Aurobindo 50 mg, filmomhulde tabletten voriconazol
Maltese: Voriconazol Aurobindo 50 mg, filmomhulde tabletten vorikonażol
English: Betahistin HEXAL 24 mg Tabletten
Maltese: Betahistin HEXAL 24 mg Tabletten betahistina
English: Voriconazol PUREN 50 mg Filmtabletten voriconazol
Maltese: Voriconazol PUREN 50 mg Filmtabletten vorikonażol
English: Oralcon 30 Microgramm/125 Microgramm Tabletten ethinylestradiol / levonorgestrel
Maltese: 30 Microgramm/125 Microgramm Tabletten etinilestradjol / levonorgestrel
English: Aurobindo Pharma Limited
Maltese: In-Norveġja Aurobindo Pharma Limited
English: Aurobindo Pharma (Malta) Limited
Maltese: Ir-Rumanija Aurobindo Pharma (Malta) Limited
English: Sandoz A/S
Maltese: L-Iżvezja Sandoz A/S
English: Aripiprazole 30 mg tablets aripiprazole
Maltese: Aripiprazole 30 mg pilloli aripiprażol
English: 1 A Pharma GmbH, Germany
Maltese: Il-Ġermanja 1 A Pharma GmbH, Il
English: Paracetamol 1000 mg Film Coated Tablets paracetamol
Maltese: Paracetamol 1000 mg FilmCoated Tablets paraċetamol
English: Hydroxyzine Sandoz hydroxyzine
Maltese: Hydroxyzine Sandoz idrossiżina
English: BETAHISTIN SANDOZ 16 MG betahistine dihydrochloride
Maltese: SANDOZ 16 MG betahistina diidroklorur
English: Betahistin HEXAL 8 mg Tabletten
Maltese: Betahistin HEXAL 8 mg Tabletten betahistina